Cipla, as an organisation has been built brick-by-brick on the foundation of care. Caring For Life has always been and continues to remain, our guiding purpose. Driven by the same purpose, we have extended our presence to 80+ countries providing over 1,500 products across various therapeutic categories in 50+ dosage forms. To make healthcare more affordable globally, we are deepening our presence in the key markets of India, South Africa, the U.S. among other economies of the emerging world.

HOF Pharmaceuticals Ltd are a pharmaceutical formulation manufacturing company that is committed to shine through its quality products and exceptional customer service. As we launch our organization in the most challenging pharmaceutical field, we are confident of success owing to our unwavering focus on quality and products that are equivalent in quality to the leading multinationals.

Accenture is a global management consulting, technology services and outsourcing company, with approximately 275,000 people serving clients in more than 120 countries. Combining unparalleled experience, comprehensive capabilities across all industries and business functions, and extensive research on the worlds most successful companies, Accenture collaborates with clients to help them become high-performance businesses and governments.

A global, full-service, technical and innovative CRO specialized in end-to-end quality clinical research and clinical trial management services along with an industry-leading suite of specialized pharmacovigilance solutions. We blend scientific and technical expertise with commitment of delivery, every single day.

Post : Clinical Research Associate (CRA)- 08 positions

Hetero Drugs is an Indian pharmaceutical company and the world’s largest producer of anti-retroviral drugs. Hetero’s business includes APIs, generics, biosimilars, custom pharmaceutical services, and branded generics. Globally renowned, vertically integrated pharmaceutical player engaged in Research and Development (R&D), manufacturing, and marketing of high-quality chemical and biologic medicines across diverse therapeutic areas.

WALK-IN INTERVIEWS FOR FRESHERS

Cognizant is one of the world's leading professional services companies, transforming clients business, operating and technology models for the digital era. Our unique industry-based, consultative approach helps clients envision, build and run more innovative and efficient businesses. Headquartered in the U.S., Cognizant is ranked 193 on the Fortune 500 and is consistently listed among the most admired companies in the world.

Temporal lobe epilepsy (TLE) is one of the most common types of epilepsy worldwide. Although symptomatic medications are available, one-third of TLE patients remain unresponsive to current treatment, so new drug targets are critically needed. A research team co-led by a City University of Hong Kong (CityU) neuroscientist recently identified and developed a new drug candidate that has potential for effectively treating TLE by suppressing neuroinflammation.

A common chemotherapy drug could carry a toxic inheritance for children and grandchildren of adolescent cancer survivors, Washington State University-led research indicates.

Bharat Biotech International Limited a global leader in vaccine innovation and developer of vaccines for infectious diseases, today announced that iNCOVACC® (BBV154), has received approval from the Central Drugs Standard Control Organisation (CDSCO) under Rcstrictcd Use in Emcrgcncy Situation for ages 18 and above, in India, for heterologous booster doses.

Nitte College of Pharmaceutical Sciences in partnership with UNICEF and Rajiv Gandhi University of Health Sciences, executed a project on Social &Behavior Change Among the Communities to Avail Health & Nutrition Services in Karnataka. It sparked off with the inaugural ceremony on 6th of May, 2022 where Dr. Kusum Devi, Principal, NCOPS emphasizedon the importance of nutrition and immunization for the well-being of the community. NSS Officer, Dr Ashwini. Mhighlighted the essence of the project and the qualities and nature of an NSS volunteer.

The National Health Mission (NHM), UP seeks to provide universal access to equitable, affordable and quality health care, which is accountable, yet at the same time responsive to the needs of the people, resulting in the reduction of child and maternal deaths, as well as population stabilization, gender and demographic balance.

NHM, U.P. is seeking applications from eligible candidates for contractual vacancies of  Pharmacist-Allopathic detail of which is mentioned below.

Malabar Cancer Centre, Thalassery is an autonomous institution under Health and Family Welfare Department, Government of Kerala, established under Societies Registration Act XXI of 1860. The institution is located at Kodiyeri, Thalassery of Kannur District and was established in 2001 and the clinical services were started in the same year.

Tata Memorial Centre is an autonomous grant-in-aid institution of the Department of Atomic Energy. TMC is comprised of the Advanced Centre for Treatment, Research and Education in Cancer (ACTREC) and the Tata Memorial Hospital (TMH). ACTREC conducts a Ph.D. program in Life Sciences, affiliated to the Homi Bhabha National Institute (a deemed university under category A by MHRD, Govt of India). On-going research at ACTREC includes basic and translational research in Cancer Biology.

The promulgation of Employees' State Insurance Act, 1948 (ESI Act), by the Parliament was the first major legislation on social Security for workers in independent India. It was a time when the industry was still in a nascent stage and the country was heavily dependent on an assortment of imported goods from the developed or fast developing countries. The deployment of manpower in manufacturing processes was limited to a few select industries such as jute, textile, chemicals etc.

Aurigene is a development stage biotech company engaged in discovery and clinical development of novel and best in class therapies to treat cancer and inflammatory diseases, and a wholly owned subsidiary of Dr. Reddy's Laboratories Ltd.

Post : Senior Scientist - DMPK (Transporters, Proteohics, Metabolite Identification & Mass Spectrometry)

Syngene International Ltd is an integrated research, development and manufacturing services company serving the global pharmaceutical, biotechnology, nutrition, animal health, consumer goods and specialty chemical sectors. Syngene’s 4500+ scientists offer both skills and the capacity to deliver great science, robust data management and IP security and quality manufacturing, at speed, to improve time-to-market and lower the cost of innovation.

Eris Lifesciences Ltd is the only publicly listed Indian pharmaceutical company with a pure-play domestic branded formulations business model. Established in 2007, Eris is by far the youngest company in the IPM Top-25. Our business ethos is based on two pillars - harnessing the power of cutting-edge science to bring evidence-based therapies to the market, and enabling our patients to take charge of their diagnoses and their lives through our patient care initiatives. Since inception, we have been focused on chronic and sub chronic lifestyle related therapies.

Cipla, as an organisation has been built brick-by-brick on the foundation of care. Caring For Life has always been and continues to remain, our guiding purpose. Driven by the same purpose, we have extended our presence to 80+ countries providing over 1,500 products across various therapeutic categories in 50+ dosage forms. To make healthcare more affordable globally, we are deepening our presence in the key markets of India, South Africa, the U.S. among other economies of the emerging world.

Syngene International Ltd is an integrated research, development and manufacturing services company serving the global pharmaceutical, biotechnology, nutrition, animal health, consumer goods and specialty chemical sectors. Syngene’s 4500+ scientists offer both skills and the capacity to deliver great science, robust data management and IP security and quality manufacturing, at speed, to improve time-to-market and lower the cost of innovation.